USPTO serial 79305107
HPGR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 27, 2022
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HPGR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biological preparations used in science; chemical reagents for non-medical purposes; chemical preparations for use as reagents for non-medical purposes; chemicals, chemical reagents and chemical preparations for scientific use in diagnostics; chemicals, chemical reagents and chemical preparations for scientific use in tests and testing; kits and assays comprising chemicals, chemical reagents and chemical preparations for scientific use; chemical assays for research purposes; kits and assays for testing biological samples comprising of chemicals and chemical preparations for scientific use; none of the foregoing goods being for medical or veterinary purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations for treatment of infectious diseases and veterinary preparations for treatment of infectious diseases for use with livestock; therapeutic preparations for medical and veterinary purposes for treatment of infectious diseases; vaccines; antibodies; medical and veterinary preparations and substances for treatment of infectious diseases; chemical, biochemical and biological reagents for medical and veterinary purposes; chemical, biochemical and biological preparations for medical and veterinary purposes for treatment of infectious diseases; diagnostic preparations for medical and veterinary use; medical and veterinary testing preparations for diagnostic use; medical and veterinary preparations for the testing and diagnosis of infectious diseases, blood grouping, virology and antibodies; kits comprised of medical diagnostic reagents and assays and also containing medical diagnostic swabs and sticks for diagnosis and testing in the medical and veterinary fields; rapid diagnostic test kits comprised of medical diagnostic reagents and assays for the diagnosis of infectious disease for home use | ACTIVE | — |
| 010 | Diagnostic, screening and analysis apparatus and instruments for use in the medical and veterinary fields, namely, diagnostic, screening and analysis apparatus and instruments for testing body fluids; chemical, biochemical and biological detection apparatus and instruments for medical and veterinary purposes, namely, kits for medical and veterinary testing purposes comprised of pipettes and test cassettes sold empty for identification of infectious diseases; portable apparatus and instruments for medical and veterinary testing purposes, namely, kits for medical and veterinary testing purposes comprised of pipettes and test cassettes sold empty for identification of infectious diseases; kits for medical and veterinary testing purposes comprised of pipettes and test cassettes sold empty for identification of the SARS-CoV-2 and influenza viruses in humans and animals; medical and veterinary apparatus and instruments, namely, kits for medical and veterinary testing purposes comprised of pipettes and test cassettes sold empty for diagnostic and testing purposes in relation to infectious diseases, blood grouping, virology and antibodies; diagnostic testing apparatus for medical purposes for testing for infectious diseases for home use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Iceni Diagnostics Limited
- Other trademarks owned by Iceni Diagnostics Limited
- Other trademarks owned by Iceni Diagnostics Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named HPGR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 7, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 18, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 18, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 27, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 27, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 27, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 16, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 27, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 27, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 18, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 12, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 22, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 22, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 22, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 7, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 7, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 19, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 19, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 19, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 19, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 19, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 19, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 27, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 26, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 5, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 1, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |